INCY Reports FDA CRL for Zynyz sBLA in NSCLC, Phase 3 POD1UM-304 Positive Data, Catalent Compliance Issue Only
Incyte Genomics Inc · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $95.59
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS